Since you were named an ASCP Forty Under 40, how does your career look different now vs then?

I am now the CEO and founder of PathOlOgics, LLC for AI-powered automated analytical and post-analytical hematopathology services. My validated online platform automatically generates comprehensive clinicopathologic correlations, including diagnosis/follow-up, prognosis, and recommendations consistent with the 2022 updates of the WHO and ICC, when genomic data are incorporated. In the absence of genomic data, this platform also provides comprehensive narratives, comments, and interpretations for CBC and peripheral blood smear reviews, including recommendations of medical necessity (if applicable). This supports the “wise selection” of genomic tests to be performed. Such a clinically-fit tool is requested to assist senior hematopathologists by saving time and effort, ensuring consistent quality, addressing workforce shortages and stress, and minimizing liability and clerical errors.

Tell us about any significant/notable achievements or breakthroughs in your work since you were named a 40 Under Forty

To advance the automation of manual blood smear analysis and morphologic examinations, I published the study "1 Million Segmented Red Blood Cells with 240 K Classified in 9 Shapes and 47 K Patches of 25 Manual Blood Smears" in Nature Scientific Data journal.

I was also honored to receive the Best Scientific Poster Award at the ASCP Annual Meeting in Chicago in 2018 for my study, "Specific Cutoffs for HOMA1-IR, HOMA2-IR, HOMA1-%B, and HOMA2-%B in Adult Egyptian Patients." Remarkably, its abstract, published in the American Journal of Clinical Pathology, has garnered nine citations by 2024—a rare achievement for a concise publication of just 250 words. In addition, I have been recognized by the American University in Cairo (AUC) for exceptional achievements and contributions in clinical laboratory medicine training program.